Lexaria Bioscience

401 posts

Lexaria Bioscience

@LexariaBioCorp

Lexaria Bioscience Corp is a research-driven company that has developed a patented DehydraTECH™ tech that promotes faster delivery of drugs into the blood $LEXX

Присоединился Temmuz 2020

758 Подписки873 Подписчики

Lexaria Bioscience@LexariaBioCorp·4 Mar

Lexaria Announces New R&D Plans for 2026 - Exciting new human and animal studies designed to enhance business opportunities lexariabioscience.com/2026/03/04/lex… $LEXX #Biotech #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

261

Lexaria Bioscience@LexariaBioCorp·6 Şub

Lexaria Announces Positive Final Results From Human Pilot Study #5 lexariabioscience.com/2026/02/05/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

1.6K

Lexaria Bioscience@LexariaBioCorp·26 Oca

Lexaria Awarded Six Additional Patents - Lexaria now has 60 patents granted around much of the world lexariabioscience.com/2026/01/22/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

694

Lexaria Bioscience@LexariaBioCorp·14 Oca

Lexaria Releases Annual Letter from the CEO lexariabioscience.com/2026/01/12/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

344

Lexaria Bioscience@LexariaBioCorp·5 Oca

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 lexariabioscience.com/2025/12/30/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

1.6K

Lexaria Bioscience@LexariaBioCorp·23 Ara

Primary Endpoint Successfully Achieved in Lexaria’s Phase 1b Study GLP-1-H24-4 lexariabioscience.com/2025/12/23/pri… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

Lexaria Bioscience@LexariaBioCorp·12 Kas

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended lexariabioscience.com/2025/11/12/mat… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

970

Lexaria Bioscience@LexariaBioCorp·10 Eki

Lexaria Bioscience Corp. Provides Strategic Update lexariabioscience.com/2025/10/09/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

381

Lexaria Bioscience@LexariaBioCorp·19 Eyl

Lexaria’s Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain lexariabioscience.com/2025/09/19/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

645

Lexaria Bioscience@LexariaBioCorp·14 Ağu

Lexaria’s Phase 1b GLP-1 Study Achieves Important “Last Patient Last Visit” Milestone lexariabioscience.com/2025/08/14/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

236

Lexaria Bioscience@LexariaBioCorp·6 Ağu

GLP-1 “Arms Race” Broadens to Include Dozens of Companies - Lexaria highlights DehydraTECH’s adverse events improvement opportunity lexariabioscience.com/2025/08/06/glp… $LEXX #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

174

Lexaria Bioscience@LexariaBioCorp·28 Tem

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b Study lexariabioscience.com/2025/07/28/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

236

Lexaria Bioscience@LexariaBioCorp·23 Tem

Lexaria’s DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry lexariabioscience.com/2025/07/23/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

191

Lexaria Bioscience@LexariaBioCorp·25 Haz

Lexaria Reaches Patent Milestone – 50 Patents Now Granted Worldwide!! lexariabioscience.com/2025/06/23/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #patent

English

Lexaria Bioscience@LexariaBioCorp·13 Haz

Lexaria’s DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule lexariabioscience.com/2025/06/11/lex… $LEXX #Biotech #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

Lexaria Bioscience@LexariaBioCorp·5 Haz

Lexaria Attending BIO International Convention - Biotechnology Sector’s Premier Strategic Partnering Event lexariabioscience.com/2025/06/05/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes

English

Lexaria Bioscience@LexariaBioCorp·12 May

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company lexariabioscience.com/2025/05/12/lex… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading

English

Lexaria Bioscience@LexariaBioCorp·23 Nis

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology lexariabioscience.com/2025/04/23/rec… $LEXX #Biotech #DrugDelivery #markets #stocks #stockmarket #investing #trading #weightloss #glp1 #diabetes

English

105

Lexaria Bioscience@LexariaBioCorp·14 Nis

Lexaria Updates its Ongoing Human Study GLP-1-H24-4 - Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss lexariabioscience.com/2025/04/03/lex… $LEXX #Biotech #DrugDelivery #markets #stocks #stockmarket #investing #trading #weightloss #glp1 #diabetes

English

Lexaria Bioscience@LexariaBioCorp·14 Nis

Lexaria’s Human GLP-1 Study #5 Begins Dosing - Head-to-head human study comparing traditional injected liraglutide to first-ever oral DehydraTECH-liraglutide lexariabioscience.com/2025/04/02/lex… $LEXX #markets #stocks #stockmarket #investing #trading #weightloss #glp1 #diabetes

English

Открыть

@elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA @nikifrancismediavine @katyperry